Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 USD | +3.64% | +17.24% | +8.97% |
04-25 | Compass Therapeutics Gets FDA Fast-Track Designation for Biliary Tract Cancer Treatment | MT |
04-25 | Compass Therapeutics Gets FDA Fast-Track for Cancer Treatment | DJ |
Business Summary
Number of employees: 32
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 16-12-31 | |
Thomas Schuetz
FOU | Founder | 63 | 13-12-31 |
Neil Lerner
DFI | Director of Finance/CFO | 56 | 19-12-31 |
Karin Herrera
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Minori Rosales
CTO | Chief Tech/Sci/R&D Officer | 61 | 23-04-30 |
General Counsel | - | 21-07-31 | |
Ian Chia
PRN | Corporate Officer/Principal | - | 17-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Lindahl
BRD | Director/Board Member | 70 | 23-04-20 |
Mary Gray
BRD | Director/Board Member | 71 | 22-04-24 |
Ellen Chiniara
BRD | Director/Board Member | 65 | 22-04-24 |
Carl Gordon
CHM | Chairman | 59 | 14-12-31 |
Phil Ferneau
BRD | Director/Board Member | 62 | 14-12-31 |
Thomas Schuetz
FOU | Founder | 63 | 13-12-31 |
James Boylan
BRD | Director/Board Member | 57 | 22-10-31 |
Chief Executive Officer | 53 | 16-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 137,589,171 | 119,101,964 ( 86.56 %) | 0 | 86.56 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.97% | 227M | |
-1.21% | 103B | |
+8.76% | 101B | |
+4.40% | 23.07B | |
-12.09% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.03% | 16.94B | |
+6.83% | 14.07B | |
+39.06% | 12.35B |
- Stock Market
- Equities
- CMPX Stock
- Company Compass Therapeutics, Inc.